Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Steen, Christel ^a   Wilczak, Nadine ^a   Hoogduin, Johannes M ^a,b   Koch, Marcus ^a   de Keyser, Jacques ^a,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA INTERFERON; CREATINE; CREATINE KINASE; CREATINE KINASE B; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID; UNCLASSIFIED DRUG; ASPARTIC ACID; CREATINE KINASE BB; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN HOMOGENATE; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; OLIGODENDROGLIA; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER; BIOLOGICAL MODEL; BRAIN; CADAVER; CASE CONTROL STUDY; ENZYMOLOGY; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY;

ADENOSINE TRIPHOSPHATE; ASPARTIC ACID; ASTROCYTES; BRAIN; CASE-CONTROL STUDIES; CREATINE KINASE, BB FORM; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; PHOSPHOCREATINE; POSTMORTEM CHANGES;

EID: 77956278552     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010811     Document Type: Article

References (39)

1. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55: 458-468.
2. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717.
3. Henderson AP, Barnett MH, Parratt JD, Prineas JW (2009) Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 66: 739-753.
4. Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129: 606-616.
5. Koch M, Mostert J, Heersema D, De Keyser J (2007) Progression in multiple sclerosis: further evidence of an age dependent process. J Neurol Sci 255: 35-41.
6. Metz I, Lucchinetti CF, Openshaw H, Garcia-Merino A, Lassmann H, et al. (2007) Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 130: 1254-1262.
7. Raine CS (1984) On the association between perinodal astrocytic processes and the node of Ranvier in the C.N.S. J Neurocytol 13: 21-27.
8. Derouiche A, Frotscher M (2001) Peripheral astrocyte processes: monitoring by selective immunostaining for the actin-binding ERM proteins. Glia 36: 330-341.
9. Hertz L, Peng L, Dienel GA (2007) Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis. J Cereb Blood Flow Metab 27: 219-249.
10. Yoshimine T, Morimoto K, Homburger HA, Yanagihara T (1983) Immunohistochemical localization of creatine kinase BB-isoenzyme in human brain: comparison with tubulin and astroprotein. Brain Res 265: 101-108.
11. Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M (2004) Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci 20: 144-160.
12. Thompson RJ, Kynoch PA, Sarjant J (1980) Immunohistochemical localization of creatine kinase-BB isoenzyme to astrocytes in human brain. Brain Res 201: 423-426.
13. Anderson CM, Swanson RA (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32: 1-14.
14. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65: 1-105.
15. Minderhoud JM, Mooyaart EL, Kamman RL, Teelken AW, Hoogstraten MC, et al. (1992) In vivo phosphorus magnetic resonance spectroscopy in multiple sclerosis. Arch Neurol 49: 161-165.
16. Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, et al. (1994) Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol 36: 157-165.
17. van der Knaap MS, Pouwels PJW (2005) Magnetic resonance spectroscopy: basic principles and application in white matter disorders. In: van der Knaap MS, Valk J, eds. Magnetic resonance of myelination and myelin disorders. Berlin: Springer. pp 859-880.
18. Petroff OA, Ogino T, Alger JR (1988) High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J Neurochem 51: 163-171.
19. Aksenov M, Aksenova M, Butterfield DA, Markesbery WR (2000) Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem 74: 2520-2527.
20. Greco A, Minghetti L, Sette G, Fieschi C, Levi G (1999) Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis. Neurology 53: 1876-1879.
21. Langemann H, Kabiersch A, Newcombe J (1992) Measurement of lowmolecular- weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur Neurol 32: 248-252.
22. Koch M, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, et al. (2006) Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis. J Neurol 253: 483-487.
23. Kuzhikandathil EV, Molloy GR (1994) Transcription of the brain creatine kinase gene in glial cells is modulated by cyclic AMP-dependent protein kinase. J Neurosci Res 39: 70-82.
24. Kuzhikandathil EV, Molloy GR (1999) Proximal promoter of the rat brain creatine kinase gene lacks a consensus CRE element but is essential for the cAMP-mediated increased transcription in glioblastoma cells. J Neurosci Res 56: 371-385.
25. De Keyser J, Wilczak N, Leta R, Streetland C (1999) Astrocytes in multiple sclerosis lack beta-2 adrenergic receptors. Neurology 53: 1628-1633.
26. Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE (2007) Vesicular release of glutamate from unmyelinated axons in white matter. Nat Neurosci 10: 321-330.
27. Rose EM, Koo JC, Antflick JE, Ahmed SM, Angers S, et al. (2009) Glutamate transporter coupling to Na,K-ATPase. J Neurosci 29: 8143-8155.
28. Sonnewald U, Westergaard N, Schousboe A (1997) Glutamate transport and metabolism in astrocytes. Glia 21: 56-63.
29. Fonseca LL, Monteiro MA, Alves PM, Carrondo MJ, Santos H (2005) Cultures of rat astrocytes challenged with a steady supply of glutamate: new model to study flux distribution in the glutamate-glutamine cycle. Glia 51: 286-296.
30. Domercq M, Etxebarria E, Perez-Samartin A, Matute C (2005) Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition. Glia 52: 36-46.
31. Xu GY, Liu S, Hughes MG, McAdoo DJ (2008) Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord. Neuroscience 153: 1034-1047.
32. Werner P, Pitt D, Raine CS (2000) Glutamate excitotoxicity-a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis? J Neural Transm Suppl. pp 375-385.
33. Ouardouz M, Coderre E, Basak A, Chen A, Zamponi GW, et al. (2009) Glutamate receptors on myelinated spinal cord axons: I. GluR6 kainate receptors. Ann Neurol 65: 151-159.
34. Ouardouz M, Coderre E, Zamponi GW, Hameed S, Yin X, et al. (2009) Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors. Ann Neurol 65: 160-166.
35. Trapp BD, Stys PK (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8: 280-291.
36. Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6: 67-70.
37. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain 128: 1016-1025.
38. Sarchielli P, Greco L, Floridi A, Gallai V (2003) Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol 60: 1082-1088.
39. Vallejo-Illarramendi A, Domercq M, Perez-Cerda F, Ravid R, Matute C (2006) Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 21: 154-164.